Technology Profiles
 Profile Detail
Clinical study expertise for monitoring the characteristics of drug dosing and formulation (10 GB 46P4 3I61)
A Scottish company with expertise in early phase clinical studies seeks drug development and delivery partners. At the forefront of gamma scintigraphy (specialist, non-invasive imaging techniques), they can monitor the characteristics and behaviour of drug formulations, thereby easing decision making on dosing and formulation. Partners looking at formulation and dosing of drugs in development are sought for early stage clinical trials.
Country: United Kingdom
Type: OFFER
Date: 28.07.2010
The monitoring this Scottish company offers can be used on oral, nasal, pulmonary and ophthalmic drug delivery systems.
Specialist imaging techniques such as gamma scintigraphy allow monitoring of the in vivo characteristics and behaviour of drug formulations. Accurate scintigraphic information both alone, and in combination with pharmacokinetics, assists clients in drug development decision making (including the development of new formulations as well as re-formulation of existing products) and subsequently marketing strategies. The correct decision made at an early stage ultimately saves companies time and expense. during the drug development process.
Complying with ICH-GCP guidelines, all manufacturing is carried out in their in-house GMP (Good Manufacturing Practice) facility.
Innovative Aspects:
The Scottish company are at the forefront in gamma scintigraphy. Their services offering the following advantages:
- Non-invasive testing
- Access to patients for trials (both healthy volunteers and patient groups with relevant symptoms or conditions)
- Efficient method of determining required dosage and formulation
- Global capabilities
-Close links with world-renowned expert consultants
- Hospital base, allowing access to defined patient groups and specialist medical support
- University links provide access to new technologies
- Proven track record in the development of innovative labelling techniques
- Experienced staff dedicated to quality of service
- On-site GMP manufacturing facility
- Competitive costing
- Quick turnaround of clinical trials (from final protocol design to clinical report can take as little as 12 weeks).
Degree of development:
Patents/Rights: Secret know-how
Requested Cooperation: Testing of new applications, Adaptation to specific needs
- Type of partner sought: Any pharmaceutical or biotechnology company needing to determine the in-vivo performance of a formulation utilising a non-invasive technique.
- Specific area of activity of the partner: cardiovascular, Central Nervous System, oncology, diabetes,respiratory, nasal or occular therapeutics.
Task to be performed by the partner sought: discuss applications of this technology and how specialist imaging can be used in clinical trials. Provide therapeutics with details of dosage,contra-indications etc
Type of Organisation:
Status: NEW
| 
